Biktarvy Gilead Sciences Pty Ltd
Product name
Biktarvy
Sponsor
Accepted date
Sep-2024
Active ingredients
bictegravir sodium, emtricitabine, tenofovir alafenamide fumarate
Proposed indication
Treatment of HIV-1 infection in adults and paediatric patients.
Application type
C (new indication)
Publication date
Sep-2024